Qi Tan

497 total citations
13 papers, 335 citations indexed

About

Qi Tan is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Ophthalmology. According to data from OpenAlex, Qi Tan has authored 13 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Ophthalmology. Recurrent topics in Qi Tan's work include Ophthalmology and Visual Impairment Studies (12 papers), Corneal surgery and disorders (9 papers) and Retinal Diseases and Treatments (5 papers). Qi Tan is often cited by papers focused on Ophthalmology and Visual Impairment Studies (12 papers), Corneal surgery and disorders (9 papers) and Retinal Diseases and Treatments (5 papers). Qi Tan collaborates with scholars based in China, Hong Kong and Australia. Qi Tan's co-authors include Pauline Cho, Victor C.P. Woo, George P. M. Cheng, Alex LK Ng, Stephen J. Vincent, Alex L. K. Ng, Longqian Liu, W. F. Mader, Xue Wang and Wenqiu Zhang and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Current Eye Research and Ophthalmic and Physiological Optics.

In The Last Decade

Qi Tan

12 papers receiving 328 citations

Peers

Qi Tan
Leah Johnson United States
Aicun Fu China
Myhanh Nguyen United States
Monica Chitkara United States
Leah Johnson United States
Qi Tan
Citations per year, relative to Qi Tan Qi Tan (= 1×) peers Leah Johnson

Countries citing papers authored by Qi Tan

Since Specialization
Citations

This map shows the geographic impact of Qi Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Tan more than expected).

Fields of papers citing papers by Qi Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Tan. The network helps show where Qi Tan may publish in the future.

Co-authorship network of co-authors of Qi Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Tan. A scholar is included among the top collaborators of Qi Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Tan. Qi Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Tan, Qi, Pauline Cho, Alex L. K. Ng, et al.. (2023). Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine. Eye and Vision. 10(1). 21–21. 2 indexed citations
3.
Tan, Qi, Alex LK Ng, George P. M. Cheng, Victor C.P. Woo, & Pauline Cho. (2022). Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Contact Lens and Anterior Eye. 46(1). 101723–101723. 42 indexed citations
4.
Tan, Qi, et al.. (2020). One‐year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic and Physiological Optics. 40(5). 557–566. 53 indexed citations
5.
Tan, Qi, et al.. (2020). Repeatability of pupil size measurements with NIDEK OPD‐Scan III in myopic children. Ophthalmic and Physiological Optics. 41(2). 431–436. 6 indexed citations
6.
Vincent, Stephen J., Qi Tan, Alex L. K. Ng, et al.. (2020). Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control. Ophthalmic and Physiological Optics. 40(6). 728–737. 31 indexed citations
7.
Tan, Qi, et al.. (2019). Combined atropine with orthokeratology in childhood myopia control (AOK) - A randomized controlled trial. Investigative Ophthalmology & Visual Science. 60(9). 3899–3899. 1 indexed citations
8.
Tan, Qi, Alex LK Ng, George P. M. Cheng, Victor C.P. Woo, & Pauline Cho. (2019). Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results. Current Eye Research. 44(6). 671–678. 44 indexed citations
9.
Cho, Pauline & Qi Tan. (2018). Myopia and orthokeratology for myopia control. Clinical and Experimental Optometry. 102(4). 364–377. 114 indexed citations
10.
Wu, Ye, Qi Tan, Wenqiu Zhang, et al.. (2014). Rigid gas‐permeable contact lens related life quality in keratoconic patients with different grades of severity. Clinical and Experimental Optometry. 98(2). 150–154. 37 indexed citations
11.
Tan, Qi & Longqian Liu. (2013). The principles and utilization of ETDRS chart and the comparison with Snellen chart. Chinese Journal of Optometry & Ophthalmology. 15(10). 633–636. 1 indexed citations
12.
Tan, Qi, Ming Zhang, & Longqian Liu. (2013). [Ocular higher-order aberrations in patients with neovascular age-related macular degeneration].. PubMed. 44(1). 68–71.
13.
Tan, Qi, et al.. (2011). [The estimation of higher order aberrations in children with anisometropic amblyopic].. PubMed. 28(6). 1117–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026